Letibotulinumtoxina: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Letibotulinumtoxina. Educational only — not medical advice.
Labeled uses
LETYBO is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
Source: FDA labeling via NIH DailyMed (set 910e5d0e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.